A detailed history of Capital International Investors transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Capital International Investors holds 2,117,636 shares of EW stock, worth $158 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,117,636
Previous 2,102,889 0.7%
Holding current value
$158 Million
Previous $194 Million 28.06%
% of portfolio
0.03%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$59.7 - $93.78 $880,395 - $1.38 Million
14,747 Added 0.7%
2,117,636 $140 Million
Q2 2024

Aug 13, 2024

SELL
$84.3 - $94.31 $9.61 Million - $10.8 Million
-114,013 Reduced 5.14%
2,102,889 $194 Million
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $495 Million - $652 Million
-6,824,658 Reduced 75.48%
2,216,902 $212 Million
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $1.31 Billion - $1.65 Billion
-21,212,168 Reduced 70.11%
9,041,560 $689 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $224 Million - $302 Million
3,238,696 Added 11.99%
30,253,728 $2.1 Billion
Q2 2023

Aug 11, 2023

BUY
$81.41 - $94.33 $102 Million - $118 Million
1,255,926 Added 4.88%
27,015,032 $2.55 Billion
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $224 Million - $255 Million
3,017,120 Added 13.27%
25,759,106 $2.13 Billion
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $3.04 Million - $3.89 Million
44,526 Added 0.2%
22,741,986 $1.7 Billion
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $24.2 Million - $31.5 Million
293,568 Added 1.31%
22,697,460 $1.88 Billion
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $22 Million - $32.5 Million
253,759 Added 1.15%
22,403,892 $2.13 Billion
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $22.3 Million - $28.1 Million
218,908 Added 1.0%
22,150,133 $2.61 Billion
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $133 Million - $163 Million
1,250,416 Added 6.05%
21,931,225 $2.84 Billion
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $69.8 Million - $83.2 Million
677,929 Added 3.39%
20,680,809 $2.34 Billion
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $93.5 Million - $117 Million
1,115,719 Added 5.91%
20,002,880 $2.07 Billion
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $81.6 Million - $94.1 Million
1,037,653 Added 5.81%
18,887,161 $1.58 Billion
Q4 2020

Feb 12, 2021

BUY
$71.69 - $91.23 $26.8 Million - $34.1 Million
374,318 Added 2.14%
17,849,508 $1.63 Billion
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $81.7 Million - $106 Million
1,215,774 Added 7.48%
17,475,190 $1.39 Billion
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $638 Million - $854 Million
11,093,975 Added 214.77%
16,259,416 $1.12 Billion
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $37.1 Million - $57.3 Million
707,457 Added 15.87%
5,165,441 $974 Million
Q4 2019

Feb 18, 2020

BUY
$71.7 - $82.09 $48.9 Million - $56 Million
682,490 Added 18.08%
4,457,984 $1.04 Billion
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $59.9 Million - $73.4 Million
972,660 Added 34.7%
3,775,494 $830 Million
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $156 Million - $181 Million
2,802,834 New
2,802,834 $518 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.